A United Kingdom supplier, with 1 awarded contract, totalling £435k, most recently 7 months ago.
This contract involves the supply of pharmaceuticals as specified in the requirements document. A framework agreement will be established with economic operators whose bids rank in the top three based on the award criteria outlined in section II.2.5 of the procurement data sheet. Subsequent contract
This contract involves the procurement of various medicines, divided into 127 lots, as outlined in the public procurement procedure. Suppliers are invited to submit their offers for these lots, adhering to the conditions specified in the Terms of Reference. Suppliers have 18 days to request clarific
The contract involves the supply of radioactive pharmaceuticals, specifically radioisotopes and targeted radiolabeled molecules. These products are essential for clinical diagnostics and treatment, playing a crucial role in personalized diagnostic algorithms within precision medicine for an increasi
The contracting authority is seeking to purchase oncological medicines through an open bidding procedure. This will result in a framework agreement lasting 24 months with the top three bidders declared as winners. The contracting authority will respond clearly and completely to all clarification req
This contract involves establishing a framework agreement for the supply of essential oncology medicines for hospital medical activities, divided into 59 lots. Each lot includes a detailed list with descriptions, quantities, and estimated values for both minimum and maximum contracts related to subs
This procurement opportunity involves the acquisition of various medicines, divided into 304 lots. The contracting authority will purchase a range of medications as specified in the procurement documents. The estimated value of the largest subsequent contract is detailed in section 3 of the specific
